SC
ABBV icon

Syon Capital’s AbbVie ABBV Stock Holding History

Syon Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.85M Buy
27,228
+1,390
+5% +$299K 0.3% 57
2026
Q1 		$5.62M Sell
25,838
-79
-0.3% -$17.5K 0.28% 54
2025
Q4 		$5.92M Buy
25,917
+1,078
+4% +$246K 0.3% 53
2025
Q3 		$5.75M Buy
24,839
+3,491
+16% +$711K 0.31% 53
2025
Q2 		$3.96M Sell
21,348
-1,377
-6% -$256K 0.26% 64
2025
Q1 		$4.76M Buy
22,725
+1,680
+8% +$327K 0.39% 53
2024
Q4 		$3.74M Buy
21,045
+3,371
+19% +$620K 0.34% 57
2024
Q3 		$3.49M Buy
17,674
+474
+3% +$88.5K 0.31% 57
2024
Q2 		$2.95M Sell
17,200
-749
-4% -$124K 0.27% 62
2024
Q1 		$3.27M Buy
17,949
+1,615
+10% +$278K 0.31% 59
2023
Q4 		$2.53M Buy
16,334
+4,962
+44% +$723K 0.26% 66
2023
Q3 		$1.7M Buy
+11,372
New +$1.67M 0.21% 70

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Syon Capital's ABBV Position: Q2 2026 in Review

Syon Capital increased its AbbVie (ABBV) stake by 5.4% in Q2 2026, buying an estimated $299K and bringing the position to 27,228 shares worth $6.85M. The position accounts for 0.3% of the portfolio, ranked #57.

Syon Capital first reported a position in ABBV in Q3 2023 and has held it in 12 quarters since. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Syon Capital held 27,228 shares of AbbVie worth $6.85M as of Q2 2026.
  • Syon Capital bought 1,390 AbbVie shares in Q2 2026, an estimated $299K.
  • AbbVie made up 0.3% of Syon Capital's portfolio in Q2 2026, its #57 holding.
  • Syon Capital first reported a position in AbbVie in Q3 2023 and has held it in 12 quarters since.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.